4 East Street, Macksville is a 3 bedroom house. What are the key property features of 4 East Street, Macksville? To enquire about specific property features for 4 East Street, Macksville ...

To enquire about specific property features for 7 Partridge Street, Macksville, contact the agent. What is the size of the property at 7 Partridge Street, Macksville? The external land size for 7 ...

Today's court listings are published as part of News Corporation's commitment to public interest journalism and are compiled from information made publicly available by the courts in each State ...

The NSW SES advises people in the following area(s) to STAY INFORMED about predicted possible major flooding on the Nambucca River: North Macksville Kings Point Macksville CBD You should stay ...

The NSW SES advises people in the following area(s) to STAY INFORMED about predicted possible major flooding on the Nambucca River: Bowraville North Macksville Kings Point Macksville CBD You ...

Followed categories will be added to My News. Cohen Tasker appeared in Macksville Local Court on Thursday to be sentenced for the attack which his lawyer said was “not violence for the sake of ...

SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird”) today announced that it has entered into a definitive agreement to be acquired by funds managed by global ...

Flying high as one of the world’s premier developers of gene therapies in early 2018, bluebird bio’s share price hit a dizzying $2,300 apiece. But seven years later—after failing to build a ...

Bluebird bio will be acquired by investment firms Carlyle and SK Capital Partners, marking the end to its turbulent time as a publicly traded company. The agreement comes after years of financial ...

Shares of bluebird bio (NASDAQ:BLUE) continued their downward descent Monday in the wake of news that the company has agreed to be taken private by Carlyle Group (NASDAQ:CG) and SK Capital ...

For a full version of this story, visit STAT. Bluebird Bio announced Friday it would sell itself and its portfolio of gene therapies to the investment firms Carlyle and SK Capital for less than $ ...

Bluebird Bio (NASDAQ: BLUE) said its planned acquisition by two investment firms is, according to its board, “in the best interest of stockholders”—but enough of them felt otherwise on ...